Free Trial
OTCMKTS:GPLB

Green Planet Bioengineering (GPLB) Stock Price, News & Analysis

$0.04 0.00 (0.00%)
As of 07/3/2025

About Green Planet Bioengineering Stock (OTCMKTS:GPLB)

Key Stats

Today's Range
$0.04
$0.04
50-Day Range
$0.04
$0.20
52-Week Range
$0.02
$0.70
Volume
N/A
Average Volume
3,055 shs
Market Capitalization
$800.40 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GPLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Green Planet Bioengineering and its competitors with MarketBeat's FREE daily newsletter.

GPLB Stock News Headlines

Green Planet Bio Engineering changes auditors
Green Planet Bioengineering Co., Ltd. (GPLB)
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
The Green Planet Badge Quiz
Green Planet Bioengineering Co Ltd GPLB
Make your own Green Planet inspired seed balls
Green Planet Bioengineering Co. Ltd.
See More Headlines

GPLB Stock Analysis - Frequently Asked Questions

Green Planet Bioengineering's stock was trading at $0.54 at the beginning of the year. Since then, GPLB stock has decreased by 92.6% and is now trading at $0.04.

Shares of GPLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Green Planet Bioengineering investors own include Warner Music Group (WMG), Verizon Communications (VZ) and Evonik Industries (EVK).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Finance
Industry
Financial Conglomerates
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:GPLB
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$800.40 thousand
Optionable
Not Optionable
Beta
3.07
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:GPLB) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners